Citations

Showing 10 of 108083 citations.

Daratumumab Plus Lenalidomide and Dexamethasone in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Maia Age Subgroup Analysis
Kumar, Shaji , Plesner, Torben , Hulin, Cyrille , Venner, Christopher P. , Tiab, Mourad, Macro, Margaret , Leleu, Xavier , Pei, Huiling , Carson, Robin, Borgsten, Fredrik, Goldschmidt, Hartmut , Facon, Thierry T.F. , Weisel, Katja C , Usmani, Saad Z. , Moreau, Philippe , Orlowski, Robert Z. , Bahlis, Nizar Jacques , Basu, Supratik , Nahi, Hareth , Quach, Hang , O’Dwyer, Michael , Perrot, Aurore , Raje, Noopur , Frenzel, Laurent

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10133-10136

10.1182/blood-2022-163555 Get It

Fixed Duration Daratumumab, Ixazomib, Lenalidomide, and Dexamethasone Quadruplet for Newly Diagnosed Multiple Myeloma - MRD Negativity and Survival Outcomes
Kumar, Shaji , LaPlant, Betsy, Asmus, Erik, Thompson, Melanie , Warsame, Rahma , Kourelis, Taxiarchis , Hwa, Yi L. , Fonder, Amie , Hobbs, Miriam, Lacy, Martha Q. , Hayman, Suzanne R. , Kapoor, Prashant , Buadi, Francis K. , Gonsalves, Wilson I. , Muchtar, Eli , Dingli, David , Thompson, Melanie Ann, Go, Ronald S. , Dispenzieri, Angela , Leung, Nelson , Binder, Moritz , Rajkumar, S. Vincent , Gertz, Morie A.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10142-10143

10.1182/blood-2022-169046 Get It

Secreted Sars-Cov-2 Encoded ORF8 Protein Stimulates Pro-Inflammatory Cytokines and Predicts Severe Clinical Outcome
Wu, Xiaosheng , Ruan, Gordon , Witter, Taylor L. , Gwin, Kimberly, Nowakowski, Kevin E., Abeykoon, Jithma P. , Tang, Xinyi , Yu, Yue , Dasari, Surendra , Ansell, Stephen M. , Schellenberg, Matthew J. , Manske, Michelle K. , Tang, Xinyi, Paludo, Jonas , Badley, Andrew D. , Witzig, Thomas E.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 42-43

10.1182/blood-2022-162574 Get It

Clinical Benefit Associated with Biomarker Changes Indicative of Disease Modification in Patients with Myelofibrosis Treated with the BET Inhibitor Pelabresib As Monotherapy or in Combination with Ruxolitinib
Kremyanskaya, Marina , Rampal, Raajit K. , Patriarca, Andrea, Zavidij, Oksana, Chang, Tzuu-Wang, Taverna, Pietro, Harrison, Claire , Scandura, Joseph Michael , Verstovšek, Srđan , Talpaz, Moshe , Vannucchi, Alessandro M. , Gupta, Vikas , Palandri, Francesca , Patriarca, Andrea , Bose, Prithviraj , Chen, Dong , Cui, Jike , Mascarenhas, John

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1523-1525

10.1182/blood-2022-159409 Get It

Vκ*MYC Mouse Model Recapitulates Key Genomic Defining Events in Multiple Myeloma
Du, Megan T. , Chesi, Marta, Maura, Francesco , Coffey, David Glen , Braggio, Esteban , Stein, Caleb K. , Sharik, Meaghen E. , Ziccheddu, Bachisio , Morgan, Gareth J. , Landgren, Ola , Bergsagel, P. Leif , Chesi, Marta

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1540-1541

10.1182/blood-2022-166614 Get It

Odronextamab in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Grade 1-3a: Results from a Prespecified Analysis of the Pivotal Phase II Study ELM-2
Novelli, Silvana , Poon, Michelle, Champion, Rebecca A., Guidez, Stéphanie , Alonso, Aránzazu Alonso, Jagadeesh, Deepa, Cai, Jingxian, Oliveira, Carolina Leite De, Zhu, Min , Chaudhry, Aafia, Ambati, Srikanth, Kim, Tae Min , Taszner, Michał , Cho, Seok‐Goo , Gouill, Steven Le , Villasboas, José C. , Champion, Rebecca, Bachy, Emmanuel , Alonso, Aránzazu , Jagadeesh, Deepa , Merli, Michele , Tucker, David , Mohamed, Hesham , Luminari, Stefano

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2280-2282

10.1182/blood-2022-158404 Get It

Validation of Natural Language Processing for the Identification of Venous Thromboembolism in Radiologic Reports
Scott, David M, Houghton, Damon E. , Kreuziger, Lisa Baumann

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2794-2794

10.1182/blood-2022-163708 Get It

A Pilot Study of Azacitidine As Epigenetic Priming for Chemotherapy in Infants Less Than 1 Year of Age with KMT2A-Rearranged Acute Lymphoblastic Leukemia (ALL); Results from the Children's Oncology Group (COG) Trial AALL15P1
Kairalla, John A. , Hibbitts, Emily , Carroll, Andrew J. , Heerema, Nyla A. , Kubaney, Holly R. , August, Amanda, Wechsler, Daniel S. , Miles, Rodney R., Kihei, Cynthia D., Gore, Lia , Raetz, Elizabeth A. , Brown, Patrick A. , Guest, Erin M. , Devidas, Meenakshi , Pauly, Melinda , Reid, Joel M. , Hunger, Stephen P. , Loh, Mignon L.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3256-3257

10.1182/blood-2022-167765 Get It

An Ex Vivo Monocyte Stimulation Test Predicts Severity of COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia (CLL)
Ruan, Gordon , Wu, Xiaosheng , Gwin, Kimberly, Abeykoon, Jithma P. , Witter, Taylor L. , Schellenberg, Matthew J. , Achenbach, Sara J., Manske, Michelle K. , Rabe, Kari G. , Kay, Neil E. , Parikh, Sameer A. , Witzig, Thomas E.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 8314-8315

10.1182/blood-2022-156815 Get It